Dr Lloyd's evidence to the Inquiry was that running a trial on the more effective second-generation tests instead of starting general screening was illogical.
Linked evidence
Chronology Information
Date:
Chapter/issue
Hepatitis C Screening
Key Person(s)
Dr Huw Lloyd